Company / Cost of Revenue
HARROW, INC. Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$67.9M
FY2025
5-year range
$18.2M / $67.9M
FY2021-FY2025
Trend
+38.0%
vs FY2024
Sector context
#54 of 85
Health Care
What the data says
At $68M, HARROW, INC.'s cost of revenue ranks #32 of 85 in the Health Care sector. Cost of Revenue has increased for 5 consecutive years, from $14M in FY2020 to $68M in FY2025.
Based on SEC 10-K filings.
$68M in FY2025 with a 5-year CAGR of +36.3%.
Increased from $40M to $68M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +38.8%
- 5-Year CAGR
- +36.3%
- 10-Year CAGR
- -
Sector benchmark
#32 of 85 in Health CareTop 36% of 85This company $67.9M Sector average $2.0B
▼
-96.6% below sector average
Key checks
Key Insights
- HARROW, INC.'s cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +36.3%, indicating consistent growth.
- In FY2025, cost of revenue increased 38.0% year-over-year.
- Ranks #54 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $67.9M | +38.0% |
| FY2024 | $49.2M | +24.2% |
| FY2023 | $39.6M | +56.2% |
| FY2022 | $25.4M | +39.4% |
| FY2021 | $18.2M | +25.9% |
| FY2020 | $14.5M | -12.5% |
| FY2019 | $16.5M | +0.0% |
| FY2018 | $16.5M | +22.3% |
| FY2017 | $13.5M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026